GNLY and neoplasm: The significantly higher baseline expression of granzyme and granulysin in the tumor microenvironment of patients who subsequently experience pCR are consistent with the preclinical models that indicate synergy between cytotoxic T cell activity and the antitumor effect of chemotherapy [2, 3].